Published in Cell on May 01, 1983
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci U S A (2002) 11.11
Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol (1996) 6.22
Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J (1991) 6.13
Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants. J Virol (1984) 5.89
Genetic analysis of adeno-associated virus: properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function. J Virol (1984) 4.98
Adeno-associated virus general transduction vectors: analysis of proviral structures. J Virol (1988) 4.64
Gene therapy vectors based on adeno-associated virus type 1. J Virol (1999) 4.63
A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J Virol (1987) 4.57
Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol (1986) 4.33
Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci U S A (1984) 3.92
Positive and negative autoregulation of the adeno-associated virus type 2 genome. J Virol (1986) 3.67
Factors that bind to adeno-associated virus terminal repeats. J Virol (1989) 3.56
Replication of adeno-associated virus in synchronized cells without the addition of a helper virus. J Virol (1987) 3.44
Parvovirus replication. Microbiol Rev (1990) 3.37
Negative and positive regulation in trans of gene expression from adeno-associated virus vectors in mammalian cells by a viral rep gene product. Mol Cell Biol (1986) 3.34
Adeno-associated virus gene expression inhibits cellular transformation by heterologous genes. Mol Cell Biol (1987) 2.85
Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization. J Virol (1992) 2.84
Features of the adeno-associated virus origin involved in substrate recognition by the viral Rep protein. J Virol (1993) 2.69
Evidence for covalent attachment of the adeno-associated virus (AAV) rep protein to the ends of the AAV genome. J Virol (1990) 2.62
Identification of nuclear proteins that specifically interact with adeno-associated virus type 2 inverted terminal repeat hairpin DNA. J Virol (1989) 2.60
Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein. J Virol (1989) 2.53
Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein. J Virol (1994) 2.52
Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver. J Virol (1999) 2.37
Sequence requirements for binding of Rep68 to the adeno-associated virus terminal repeats. J Virol (1996) 2.32
Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro. J Virol (1997) 2.32
Sequences required for coordinate induction of adeno-associated virus p19 and p40 promoters by Rep protein. J Virol (1991) 2.31
Adeno-associated virus vector for high-frequency integration, expression, and rescue of genes in mammalian cells. Mol Cell Biol (1985) 2.21
Role for highly regulated rep gene expression in adeno-associated virus vector production. J Virol (1997) 2.19
Rescue of functional replication origins from embedded configurations in a plasmid carrying the adenovirus genome. Mol Cell Biol (1984) 2.14
In vitro replication of adeno-associated virus DNA. J Virol (1994) 2.09
Adeno-associated virus vector integration junctions. J Virol (1997) 2.03
Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses. J Virol (2001) 1.98
Sequence requirements for stable binding and function of Rep68 on the adeno-associated virus type 2 inverted terminal repeats. J Virol (1994) 1.98
Adeno-associated virus P5 promoter contains an adenovirus E1A-inducible element and a binding site for the major late transcription factor. J Virol (1989) 1.96
Conformation takes precedence over sequence in adeno-associated virus DNA replication. Mol Cell Biol (1984) 1.96
Colocalization of adeno-associated virus Rep and capsid proteins in the nuclei of infected cells. J Virol (1992) 1.86
Adeno-associated virus proteins: origin of the capsid components. J Virol (1984) 1.84
Analysis of mutations in adeno-associated virus Rep protein in vivo and in vitro. J Virol (1992) 1.74
Characterization of genome integrity for oversized recombinant AAV vector. Mol Ther (2009) 1.71
Replication of adeno-associated virus in cells irradiated with UV light at 254 nm. J Virol (1989) 1.67
The Rep52 gene product of adeno-associated virus is a DNA helicase with 3'-to-5' polarity. J Virol (1998) 1.61
In vitro replication of adeno-associated virus DNA. Proc Natl Acad Sci U S A (1992) 1.60
A novel 165-base-pair terminal repeat sequence is the sole cis requirement for the adeno-associated virus life cycle. J Virol (1997) 1.57
Adeno-associated virus DNA replication in vitro: activation by a maltose binding protein/Rep 68 fusion protein. J Virol (1994) 1.56
Transduction of nonhuman primate brain with adeno-associated virus serotype 1: vector trafficking and immune response. Hum Gene Ther (2009) 1.55
Modification of some biological properties of HeLa cells containing adeno-associated virus DNA integrated into chromosome 17. J Virol (1992) 1.45
Recombinant adeno-associated virus transduction and integration. Mol Ther (2008) 1.44
The adeno-associated virus rep gene inhibits replication of an adeno-associated virus/simian virus 40 hybrid genome in cos-7 cells. J Virol (1988) 1.42
Cloning of an avian adeno-associated virus (AAAV) and generation of recombinant AAAV particles. J Virol (2003) 1.37
Liver transduction with recombinant adeno-associated virus is primarily restricted by capsid serotype not vector genotype. J Virol (2006) 1.36
In vitro resolution of adeno-associated virus DNA hairpin termini by wild-type Rep protein is inhibited by a dominant-negative mutant of rep. J Virol (1992) 1.36
Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success--a personal perspective. Hum Gene Ther (2015) 1.27
Adeno-associated virus type 2 DNA replication in vivo: mutation analyses of the D sequence in viral inverted terminal repeats. J Virol (1997) 1.27
The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells. J Virol (2003) 1.26
In vitro excision of adeno-associated virus DNA from recombinant plasmids: isolation of an enzyme fraction from HeLa cells that cleaves DNA at poly(G) sequences. Mol Cell Biol (1988) 1.26
Mutational analysis of the adeno-associated virus type 2 Rep68 protein helicase motifs. J Virol (1997) 1.25
Mutational analysis of the adeno-associated virus Rep68 protein: identification of critical residues necessary for site-specific endonuclease activity. J Virol (1997) 1.24
In vitro packaging of adeno-associated virus DNA. J Virol (1998) 1.22
Adeno-associated virus (AAV) site-specific recombination does not require a Rep-dependent origin of replication within the AAV terminal repeat. Proc Natl Acad Sci U S A (2001) 1.21
Both excision and replication of cloned autonomous parvovirus DNA require the NS1 (rep) protein. J Virol (1989) 1.19
Capsid-specific T-cell responses to natural infections with adeno-associated viruses in humans differ from those of nonhuman primates. Mol Ther (2011) 1.18
Mechanism of Rep-mediated adeno-associated virus origin nicking. J Virol (2000) 1.17
Construction of a recombinant human parvovirus B19: adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in an AAV-B19 hybrid virus. Proc Natl Acad Sci U S A (1989) 1.17
Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap. J Virol (1997) 1.13
Parvovirus NS1 stimulates P4 expression by interaction with the terminal repeats and through DNA amplification. J Virol (1991) 1.13
Structure of simian virus 40-adeno-associated virus recombinant genomes. J Virol (1985) 1.13
A novel terminal resolution-like site in the adeno-associated virus type 2 genome. J Virol (1997) 1.13
Mutational analysis of adeno-associated virus type 2 Rep68 protein endonuclease activity on partially single-stranded substrates. J Virol (2000) 1.06
Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination. J Virol (1998) 1.06
Native molecular state of adeno-associated viral vectors revealed by single-molecule sequencing. Hum Gene Ther (2011) 1.05
Identical ends are not required for the equal encapsidation of plus- and minus-strand parvovirus LuIII DNA. J Virol (1989) 1.05
Parvovirus B19 promoter at map unit 6 confers autonomous replication competence and erythroid specificity to adeno-associated virus 2 in primary human hematopoietic progenitor cells. Proc Natl Acad Sci U S A (1995) 0.99
Interaction of virally coded protein and a cell cycle-regulated cellular protein with the bovine parvovirus left terminus ori. J Virol (1990) 0.99
Analysis of the termini of the DNA of bovine parvovirus: demonstration of sequence inversion at the left terminus and its implication for the replication model. J Virol (1988) 0.97
A cis-acting element that directs circular adeno-associated virus replication and packaging. J Virol (2002) 0.96
Detection of template strand switching during initiation and termination of DNA replication of porcine circovirus. J Virol (2004) 0.95
Genomic clones of bovine parvovirus: construction and effect of deletions and terminal sequence inversions on infectivity. J Virol (1988) 0.95
Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease. Int J Hypertens (2010) 0.95
Factors affecting the terminal resolution site endonuclease, helicase, and ATPase activities of adeno-associated virus type 2 Rep proteins. J Virol (1999) 0.95
The capsid proteins of Aleutian mink disease virus activate caspases and are specifically cleaved during infection. J Virol (2009) 0.95
AAV recombineering with single strand oligonucleotides. PLoS One (2009) 0.94
Palindrome regeneration by template strand-switching mechanism at the origin of DNA replication of porcine circovirus via the rolling-circle melting-pot replication model. J Virol (2004) 0.92
Recombinant adeno-associated viral vector production and purification. Methods Mol Biol (2012) 0.92
Structural insights into adeno-associated virus serotype 5. J Virol (2013) 0.92
Two spatially distinct genetic elements constitute a bipartite DNA replication origin in the minute virus of mice genome. J Virol (1991) 0.91
Analysis of the effects of charge cluster mutations in adeno-associated virus Rep68 protein in vitro. J Virol (1999) 0.90
Enhanced transgene expression from recombinant single-stranded D-sequence-substituted adeno-associated virus vectors in human cell lines in vitro and in murine hepatocytes in vivo. J Virol (2014) 0.89
The transcriptional regulator YY1 binds to the 5'-terminal region of B19 parvovirus and regulates P6 promoter activity. J Virol (1994) 0.88
Rescue of the adeno-associated virus genome from a plasmid vector: evidence for rescue by replication. J Virol (2003) 0.87
AAV-mediated tyrosinase gene transfer restores melanogenesis and retinal function in a model of oculo-cutaneous albinism type I (OCA1). Mol Ther (2009) 0.87
Identification and characterization of an adeno-associated virus integration site in CV-1 cells from the African green monkey. J Virol (2003) 0.87
Studies of the mechanism of transactivation of the adeno-associated virus p19 promoter by Rep protein. J Virol (2002) 0.87
Biophysical and ultrastructural characterization of adeno-associated virus capsid uncoating and genome release. J Virol (2012) 0.87
Charge-to-alanine mutagenesis of the adeno-associated virus type 2 Rep78/68 proteins yields temperature-sensitive and magnesium-dependent variants. J Virol (1999) 0.86
Differential suppression of the tumorigenicity of HeLa and SiHa cells by adeno-associated virus. Br J Cancer (1996) 0.86
Rescue and autonomous replication of adeno-associated virus type 2 genomes containing Rep-binding site mutations in the viral p5 promoter. J Virol (1998) 0.85
Creating a novel origin of replication through modulating DNA-protein interfaces. PLoS One (2010) 0.84
AAV-6 mediated efficient transduction of mouse lower airways. Virology (2011) 0.84
Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol (1998) 8.45
Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther (1999) 7.96
Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol (1998) 7.76
Nucleotide sequence and organization of the adeno-associated virus 2 genome. J Virol (1983) 7.52
Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A (1990) 7.06
Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol (1996) 6.43
Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol (1996) 6.22
The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity. Cell (1990) 5.98
Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants. J Virol (1984) 5.89
Evidence for a single-stranded adenovirus-associated virus genome: formation of a DNA density hybrid on release of viral DNA. Proc Natl Acad Sci U S A (1969) 5.78
Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc Natl Acad Sci U S A (1982) 5.73
Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med (1999) 5.50
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet (1994) 5.49
AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med (1999) 5.26
Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells. J Virol (1980) 5.09
Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Ther (2003) 4.92
A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol (1996) 4.83
Evidence for a single-stranded adenovirus-associated virus genome: isolation and separation of complementary single strands. J Virol (1970) 4.73
Adeno-associated virus general transduction vectors: analysis of proviral structures. J Virol (1988) 4.64
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost (2006) 4.58
A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J Virol (1987) 4.57
Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J (1992) 4.36
Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther (2001) 4.35
Studies on the biochemical basis of spontaneous mutation. I. A comparison of the deoxyribonucleic acid polymerases of mutator, antimutator, and wild type strains of bacteriophage T4. J Biol Chem (1972) 4.11
Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci U S A (1984) 3.92
Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J Virol (2000) 3.84
Characteristics and taxonomy of Parvoviridae. Intervirology (1985) 3.70
Positive and negative autoregulation of the adeno-associated virus type 2 genome. J Virol (1986) 3.67
Delta-F508 cystic fibrosis mutation is not linked to intussusception: implications for rotavirus vaccine. J Paediatr Child Health (2003) 3.59
Factors that bind to adeno-associated virus terminal repeats. J Virol (1989) 3.56
Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNA. J Virol (1980) 3.52
Hyperacute thrombolysis with IV rtPA of acute ischemic stroke: efficacy and safety profile of 54 patients at a tertiary referral center in a developing country. Neurol India (2007) 3.52
Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics (1991) 3.47
Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol Ther (2000) 3.32
Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J Virol (2000) 3.27
In vitro resolution of covalently joined AAV chromosome ends. Cell (1990) 3.24
Characterization and localization of the naturally occurring cross-links in vaccinia virus DNA. J Mol Biol (1974) 3.20
Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc Natl Acad Sci U S A (1997) 3.16
Origin and termination of adeno-associated virus DNA replication. Virology (1977) 3.14
Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res (1996) 3.03
Adeno-associated virus gene expression inhibits cellular transformation by heterologous genes. Mol Cell Biol (1987) 2.85
Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization. J Virol (1992) 2.84
Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc Natl Acad Sci U S A (1998) 2.80
Studies on the biochemical basis of spontaneous mutation. II. The incorporation of a base and its analogue into DNA by wild-type, mutator and antimutator DNA polymerases. J Mol Biol (1974) 2.79
Detection of adeno-associated virus (AAV)-specific nucleotide sequences in DNA isolated from latently infected Detroit 6 cells. Virology (1975) 2.77
Mapping of the 5' termini of two adeno-associated virus 2 RNAs in the left half of the genome. J Virol (1982) 2.75
The recombination signals for adeno-associated virus site-specific integration. Proc Natl Acad Sci U S A (1996) 2.74
Adeno-associated viruses: an update. Adv Virus Res (1987) 2.71
Features of the adeno-associated virus origin involved in substrate recognition by the viral Rep protein. J Virol (1993) 2.69
Evidence for covalent attachment of the adeno-associated virus (AAV) rep protein to the ends of the AAV genome. J Virol (1990) 2.62
Identification of nuclear proteins that specifically interact with adeno-associated virus type 2 inverted terminal repeat hairpin DNA. J Virol (1989) 2.60
Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein. J Virol (1989) 2.53
Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein. J Virol (1994) 2.52
The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost (2005) 2.45
Organization of adeno-associated virus DNA in latently infected Detroit 6 cells. Virology (1989) 2.43
Natural occurrence of cross-linked vaccinia virus deoxyribonucleic acid. J Virol (1970) 2.41
Adeno-associated viruses. Adv Virus Res (1979) 2.35
Sequence requirements for binding of Rep68 to the adeno-associated virus terminal repeats. J Virol (1996) 2.32
Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro. J Virol (1997) 2.32
Sequences required for coordinate induction of adeno-associated virus p19 and p40 promoters by Rep protein. J Virol (1991) 2.31
Arrangement of nucleotide sequences in adeno-associated virus DNA. J Mol Biol (1973) 2.30
Letter: Visualization of the inverted terminal repetition in adeno-associated virus DNA. J Mol Biol (1974) 2.25
Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence. Proc Natl Acad Sci U S A (1994) 2.25
Convergent sensing pathways mediate response to two extracellular competence factors in Bacillus subtilis. Genes Dev (1995) 2.24
Role for highly regulated rep gene expression in adeno-associated virus vector production. J Virol (1997) 2.19
Separation of two types of adeno-associated virus particles containing complementary polynucleotide chains. J Virol (1972) 2.15
Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A (1996) 2.12
Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study. Eur J Cancer Clin Oncol (1986) 2.12
Identification of a repeated sequence element required for efficient encapsidation of the adenovirus type 5 chromosome. J Virol (1987) 2.09
In vitro replication of adeno-associated virus DNA. J Virol (1994) 2.09
Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet (2001) 2.08
Selective and rapid uptake of adeno-associated virus type 2 in brain. Hum Gene Ther (1998) 2.06
X chromosome map at 75-kb STS resolution, revealing extremes of recombination and GC content. Genome Res (1997) 2.06
Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts. J Virol (2001) 2.03
Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome. J Virol (1995) 2.02
Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts. J Virol (2000) 2.01
Interaction of the adeno-associated virus Rep protein with a sequence within the A palindrome of the viral terminal repeat. J Virol (1994) 1.98
Conformation takes precedence over sequence in adeno-associated virus DNA replication. Mol Cell Biol (1984) 1.96
Should ice be used in the treatment of acute haemarthrosis in haemophilia? Haemophilia (2013) 1.92
Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression. Proc Natl Acad Sci U S A (1997) 1.91
The adeno-associated virus (AAV) Rep protein acts as both a repressor and an activator to regulate AAV transcription during a productive infection. J Virol (1997) 1.89
Sequence and symmetry requirements within the internal palindromic sequences of the adeno-associated virus terminal repeat. Virology (1988) 1.88
Colocalization of adeno-associated virus Rep and capsid proteins in the nuclei of infected cells. J Virol (1992) 1.86
Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc Natl Acad Sci U S A (1992) 1.82
Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors. Gene Ther (2001) 1.81
Insertional mutagenesis of AAV2 capsid and the production of recombinant virus. Virology (1999) 1.76
Treatment of children with newly diagnosed acute promyelocytic leukemia with arsenic trioxide: a single center experience. Leukemia (2004) 1.76
Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood (1994) 1.75
Structure and nucleotide sequence of the terminal regions of adeno-associated virus DNA. Virology (1977) 1.75
Adeno-associated virus DNA replication: nonunit-length molecules. Virology (1979) 1.74